Expertise in
1
conditions

Dr. Roshanak Monzavi

Pediatric Endocrinology | Endocrinology
4650 W Sunset Blvd, 
Los Angeles, CA 
Expertise in
1
conditions
4650 W Sunset Blvd, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Roshanak Monzavi is a Pediatric Endocrinologist and an Endocrinologist in Los Angeles, California. Dr. Monzavi is highly rated in 1 condition, according to our data. Their top areas of expertise are Type 1 Diabetes (T1D), Intersex, Klinefelter Syndrome, and Malnutrition.

Their clinical research consists of co-authoring 16 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Endocrinology
Licenses
Pediatric Endocrinology in CA
Languages Spoken
English

Insurance

Locations

4650 W Sunset Blvd, Los Angeles, CA 90027

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2025
Intervention Type: Biological
Study Drugs: Afrezza, Rapid-acting Insulin Analog, Basal Insulin
Study Phase: Phase 3
An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients With Type 1 Diabetes Aged 1 to <4 Years
An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients With Type 1 Diabetes Aged 1 to <4 Years
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Drug
Study Drug: Glucagon
Study Phase: Phase 1
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
Enrollment Status: Completed
Publish Date: May 08, 2017
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 5 Less Clinical Trials

16 Total Publications

Corrigendum to "Design and psychometrics for new measures of health-related quality of life in adults with type 1 diabetes: Type 1 Diabetes and Life (T1DAL)" [Diabetes Research and Clinical Practice 174 (2021) 108537].
Corrigendum to "Design and psychometrics for new measures of health-related quality of life in adults with type 1 diabetes: Type 1 Diabetes and Life (T1DAL)" [Diabetes Research and Clinical Practice 174 (2021) 108537].
Journal: Diabetes research and clinical practice
Published: August 04, 2021
Similar Doctors
Expertise in
20
conditions
Dr. Mitchell E. Geffner
Pediatric Endocrinology | Endocrinology
Expertise in
20
conditions
Dr. Mitchell E. Geffner
Pediatric Endocrinology | Endocrinology
4650 W Sunset Blvd, Ms# 61, 
Los Angeles, CA 
 (0.1 mi)
323-669-4606
Languages Spoken:
English
See accepted insurances

Mitchell Geffner is a Pediatric Endocrinologist and an Endocrinologist in Los Angeles, California. Dr. Geffner is highly rated in 20 conditions, according to our data. His top areas of expertise are Congenital Adrenal Hyperplasia (CAH), Intersex, Ovarian Overproduction of Androgens, Precocious Puberty, and Hormone Replacement Therapy (HRT).

Expertise in
3
conditions
Dr. Francine R. Kaufman
Pediatric Endocrinology | Endocrinology
Expertise in
3
conditions
Dr. Francine R. Kaufman
Pediatric Endocrinology | Endocrinology
4650 W Sunset Blvd, 
Los Angeles, CA 
 (0.1 mi)
323-361-3550
Languages Spoken:
English
See accepted insurances

Francine Kaufman is a Pediatric Endocrinologist and an Endocrinologist in Los Angeles, California. Dr. Kaufman is highly rated in 3 conditions, according to our data. Her top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), and Type 2 Diabetes (T2D).

Expertise in
44
conditions
Dr. John D. Carmichael
Endocrinology
Expertise in
44
conditions
Dr. John D. Carmichael
Endocrinology

USC Care Medical Group Inc

1520 San Pablo St, 
Los Angeles, CA 
 (5.5 mi)
800-872-2273
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Carmichael is an Endocrinologist in Los Angeles, California. Dr. Carmichael is highly rated in 44 conditions, according to our data. His top areas of expertise are Pituitary Tumor, Hypothalamic Tumor, Acromegaly, Endoscopic Transnasal Transsphenoidal Surgery, and Endoscopy.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Find Dr. Monzavi's expertise for a condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile